Key points are not available for this paper at this time.
Figure S3 shows proteomic analysis of SpiD3-treated CLL cells using TMT-labeling.
Eiken et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: